Connecting Gene Variation to Treatment Outcomes in Metastatic Castration-Resistant Prostate Adenocarcinoma: Insights into Second-Generation Androgen Receptor Axis-Targeted Therapies.

Int J Mol Sci · 2024 · PMC11432546 · PMID 39337362

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

marginally significantno p-value reported

In the present study, a marginally significant association between the variant rs10493112 and patients’ PFS was found, focusing on those with non-metastatic disease at PC diagnosis and under treatment with AbA (log-rank test, p = 0.056).

also in 26,082 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.